GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Australis Capital Inc (FRA:AC4) » Definitions » Other Financing

Australis Capital (FRA:AC4) Other Financing : €2.07 Mil (TTM As of Dec. 2021)


View and export this data going back to 2019. Start your Free Trial

What is Australis Capital Other Financing?

Australis Capital's Other Financing for the three months ended in Dec. 2021 was €1.77 Mil.

Australis Capital's Other Financing for the trailing twelve months (TTM) ended in Dec. 2021 was €2.07 Mil.

Australis Capital Other Financing Historical Data

The historical data trend for Australis Capital's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australis Capital Other Financing Chart

Australis Capital Annual Data
Trend Mar18 Mar19 Mar20 Mar21
Other Financing
- 2.49 1.56 -0.07

Australis Capital Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 0.03 - 0.27 1.77

Australis Capital Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Australis Capital Other Financing Related Terms

Thank you for viewing the detailed overview of Australis Capital's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Australis Capital Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Australis Capital Inc (FRA:AC4) » Definitions » Other Financing
Comparable Companies
TSXV:FLWR TSX:AVCN XCNQ:CPTR NEOE:FH TSX:LABS XCNQ:VIBE XCNQ:CLC XCNQ:YOUR TSX:VIVO XCNQ:NVG XTER:MRK ZTS TSE:4502 NSE:SUNPHARMA CTLT TSE:4507 SHSE:600196 SZSE:000538 VTRS NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
376 E. Warm Springs Road, Suite 190, Las Vegas, NV, USA, 89119
Website
https://ausa-corp.com
Australis Capital Inc operates as a multi-state operator in the cannabis industry in the US. The company is focused on brands and attractive cannabis licenses in states with favorable economics. AUSA is building an MSO based on a unique and very difficult to imitate strategy. Secure access to low-cost but high-quality biomass enables the company to fuel the expansion of its footprint across the US. The company has a rapidly growing footprint in the U.S. in states, such as California, Nevada, Massachusetts, Missouri, Oklahoma, as well as international operations through its subsidiary ALPS, with projects in Europe, Asia and North America.

Australis Capital Headlines

No Headlines